Vancomycin 250 MG Oral Capsule [Vancocin] — RxCUI 201849
RxNorm drug concept · Semantic branded drug
RxCUI 201849
Semantic branded drug · SBD
● Current RxNorm concept 2 FDA products
2 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI201849
Official nameVancomycin 250 MG Oral Capsule [Vancocin]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asVancocin 250 MG Oral Capsule; Vancocin (as vancomycin hydrochloride) 250 MG Oral Capsule
FDA products mapped2
Package NDCs mapped2
Reported Medicaid activity (SDUD)33 prescriptions · 1 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Vancomycin Injection: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- When vancomycin is given by IV, it gets directly into your bloodstream and reaches infections in your blood, heart, bones, lungs, or skin. When it's swallowed, it mostly stays in y...
- Why am I getting vancomycin by IV instead of taking a pill?
- The most common thing people notice is flushing, redness, or itching on the face, neck, and upper chest — especially if the infusion runs too fast. This is sometimes called 'Red Ma...
- What should I watch for during my vancomycin infusion?
🕸️ Concept Web — How Vancomycin 250 MG Oral Capsule [Vancocin] Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Vancomycin 250 MG Oral Capsule [Vancocin]
RxCUI 201849 Semantic branded drug · SBD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Vancomycin
11124IN
-
Vancomycin
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Vancocin
202368BN
-
Vancocin
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Vancomycin Oral Capsule
374281SCDF -
Vancomycin Oral Product
1160501SCDG -
Vancomycin Pill
1160502SCDG -
Vancomycin Oral Capsule [Vancocin]
402421SBDF -
Vancocin Oral Product
1187389SBDG -
Vancocin Pill
1187337SBDG -
Oral Capsule
316965DF -
Oral Product
1151131DFG - +1 more in this family
-
Vancomycin Oral Capsule
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Vancomycin 250 MG Oral Capsule
313571SCD -
Vancomycin 250 MG
328784SCDC -
Vancomycin 250 MG [Vancocin]
566031SBDC
-
Vancomycin 250 MG Oral Capsule
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Vancomycin 250 MG Oral Capsule
SCD · 313571 -
Vancomycin 250 MG
SCDC · 328784 -
Vancomycin Oral Capsule
SCDF · 374281 -
Vancomycin Oral Product
SCDG · 1160501 -
Vancomycin Pill
SCDG · 1160502
Brand-Name Concepts
-
Vancomycin 250 MG [Vancocin]
SBDC · 566031 -
Vancomycin Oral Capsule [Vancocin]
SBDF · 402421 -
Vancocin Oral Product
SBDG · 1187389 -
Vancocin Pill
SBDG · 1187337 -
Vancocin
BN · 202368
📦 FDA Products & Package NDCs
2 products · 2 package NDCs
2 package NDCs map to RxCUI 201849 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 62559-0310-20 | 2 BLISTER PACK in 1 CARTON (62559-310-20) / 10 CAPSULE in 1... | Vancocin | ANI Pharmaceuticals, Inc. | 2014-11-17 |
| 62559-0311-20 | 2 BLISTER PACK in 1 CARTON (62559-311-20) / 10 CAPSULE in 1... | Vancocin | ANI Pharmaceuticals, Inc. | 2014-11-17 |
Observed labelers:
ANI Pharmaceuticals, Inc. (2)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.